Chlorpropamide
From Wikipedia, the free encyclopedia
 |
|
|
Chlorpropamide
|
|
| Systematic (IUPAC) name | |
| N-(4-chlorophenyl)sulfonylmethanamide | |
| Identifiers | |
| CAS number | |
| ATC code | A10 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C10H13ClN2O3S |
| Mol. mass | 276.741 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 36 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Licence data |
|
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Chlorpropamide (Diabinese) is a sulphonylurea drug used to treat type 2 diabetes mellitus. Its renal clearance and long half-life cause hypoglycemia as a side effect more frequently than newer sulphonylureas.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
